Millenium Biologix Technologies Inc.
Records under this name other than the patents Millenium Biologix Technologies Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 1 patents it holds.
Back to Millenium Biologix Technologies Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,498,043 | Silicon Substituted Oxyapatite Formerly held Term ended Term ended Jun 24, 2026 · High confidence | Term ended | Term ended Jun 24, 2026 | High confidence |
| US 8,546,142 | Reverse flow perfusion of three-dimensional scaffolds Formerly held Lapsed on the fee record Ended Oct 1, 2025 · From the USPTO record | Lapsed on the fee record | Ended Oct 1, 2025 | From the USPTO record |
| US 8,492,140 | Automated tissue engineering system Formerly held Term ended Term ended Jun 7, 2025 · From the USPTO record | Term ended | Term ended Jun 7, 2025 | From the USPTO record |
| US 9,534,195 | Automated tissue engineering system Formerly held Term ended Term ended Aug 5, 2024 · From the USPTO record | Term ended | Term ended Aug 5, 2024 | From the USPTO record |
| US 10,723,986 | Automated tissue engineering system Formerly held Term ended Term ended May 30, 2024 · From the USPTO record | Term ended | Term ended May 30, 2024 | From the USPTO record |
| US 7,875,342 | Porous Ceramic Composite Bone Grafts Formerly held Term ended Term ended Oct 28, 2023 · High confidence | Term ended | Term ended Oct 28, 2023 | High confidence |
| US 9,701,932 | Automated tissue engineering system Formerly held Term ended Ended no later than Apr 8, 2023 · From the USPTO record | Term ended | Ended no later than Apr 8, 2023 | From the USPTO record |
| US 10,844,338 | Automated tissue engineering system Formerly held Term ended Term ended Apr 8, 2023 · From the USPTO record | Term ended | Term ended Apr 8, 2023 | From the USPTO record |
| US 6,846,493 | Synthetic Biomaterial Compound of Calcium Phosphate Phases Particularly Adapted for Supporting Bone Cell Activity Formerly held Term ended Term ended Mar 4, 2017 · Medium confidence | Term ended | Term ended Mar 4, 2017 | Medium confidence |
| US 6,585,992 | Synthetic Biomaterial Compound of Calcium Phosphate Phases Particularly Adapted for Supporting Bone Cell Activity Formerly held Term ended Term ended Jan 3, 2016 · Medium confidence | Term ended | Term ended Jan 3, 2016 | Medium confidence |